SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20188141
Source:
http://linkedlifedata.com/resource/pubmed/id/20188141
Search
Subject
(
89
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0026882
,
umls-concept:C0178566
,
umls-concept:C0450442
,
umls-concept:C0597357
,
umls-concept:C1167322
,
umls-concept:C1327915
,
umls-concept:C1523987
,
umls-concept:C1553423
,
umls-concept:C1707391
,
umls-concept:C1948023
,
umls-concept:C2584967
,
umls-concept:C2752508
pubmed:issue
5
pubmed:dateCreated
2010-4-13
pubmed:abstractText
To determine whether specific c-Mpl mutations might respond to thrombopoietin receptor agonists.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/R01 DK049855-15
,
http://linkedlifedata.com/resource/pubmed/grant/R01 DK049855-15A1
,
http://linkedlifedata.com/resource/pubmed/grant/R01 DK049855-16
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-10077649
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-10233424
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-11133753
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-15001470
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-16115772
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-16351641
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-16470591
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-17147697
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-17289815
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-18242413
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-18487512
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-18981291
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-19231632
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-19302922
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-8662939
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-8695859
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-9030560
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-9122198
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-9774108
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0402313
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-3
,
http://linkedlifedata.com/resource/pubmed/chemical/MPL protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Thrombopoietin
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Thrombopoietin
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1873-2399
pubmed:author
pubmed-author:ChenRoseR
,
pubmed-author:FoxNorma ENE
,
pubmed-author:GeddisAmy EAE
,
pubmed-author:LimJihyangJ
pubmed:copyrightInfo
2010 ISEH Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
384-91
pubmed:dateRevised
2011-7-28
pubmed:meshHeading
pubmed-meshheading:20188141-Animals
,
pubmed-meshheading:20188141-Cell Line
,
pubmed-meshheading:20188141-Cell Membrane
,
pubmed-meshheading:20188141-Humans
,
pubmed-meshheading:20188141-Hydrogen Bonding
,
pubmed-meshheading:20188141-Interleukin-3
,
pubmed-meshheading:20188141-Lymphocytes
,
pubmed-meshheading:20188141-Mice
,
pubmed-meshheading:20188141-Mutagenesis, Site-Directed
,
pubmed-meshheading:20188141-Peptides
,
pubmed-meshheading:20188141-Phosphorylation
,
pubmed-meshheading:20188141-Point Mutation
,
pubmed-meshheading:20188141-Protein Binding
,
pubmed-meshheading:20188141-Protein Interaction Mapping
,
pubmed-meshheading:20188141-Protein Processing, Post-Translational
,
pubmed-meshheading:20188141-Protein Structure, Tertiary
,
pubmed-meshheading:20188141-Receptors, Thrombopoietin
,
pubmed-meshheading:20188141-Recombinant Fusion Proteins
,
pubmed-meshheading:20188141-Recombinant Proteins
,
pubmed-meshheading:20188141-Thrombocytopenia
,
pubmed-meshheading:20188141-Thrombopoiesis
,
pubmed-meshheading:20188141-Thrombopoietin
pubmed:year
2010
pubmed:articleTitle
F104S c-Mpl responds to a transmembrane domain-binding thrombopoietin receptor agonist: proof of concept that selected receptor mutations in congenital amegakaryocytic thrombocytopenia can be stimulated with alternative thrombopoietic agents.
pubmed:affiliation
Pediatric Hematology-Oncology, University of California, San Diego, La Jolla, Calif. 92017, USA.
pubmed:publicationType
Journal Article
,
Research Support, N.I.H., Extramural